Skip to main content
. 2018 May 22;9:655. doi: 10.3389/fpls.2018.00655

Figure 6.

Figure 6

The content of (A) jasmonic acid (JA); and (B) jasmonate-isoleucine (JA-Ile). Specification of genotypes and treatments is as described in Figure 2. Data represent means ±SD (n = 6) in pmol per g DW. Statistically significant differences (p < 0.05, two-sample t-test) in JA and JA-Ile content between the corresponding variants of WT and transformants are marked (*), and between D/DC or R/RC variants within each genotype (+).